[EN] PROCESS FOR THE PREPARATION OF ARYLOXY PROPANOLAMINES<br/>[FR] PROCEDE DE PREPARATION D'ARYLOXYPROPANOLAMINES
申请人:LILLY CO ELI
公开号:WO2001036412A1
公开(公告)日:2001-05-25
Disclosed is a method of preparing and purifying an aryloxy propanolamine ester represented by structural formula (I): R1 is an aryl group or a substituted aryl group. R2 is a C1 to C6 straight or branched chain alkyl group or a C7 to C9 substituted or unsubstituted aralkyl group. The method comprises the step of reacting an epoxide starting material with an amine starting material to form the aryloxy propanolamine ester, which can then be reacted with an acid to form an ammonium salt, and crystallizing said ammonium salt. The epoxide starting material and amine starting material are represented by structural formulas, respectively (II) and (III). Purified aryloxy propanolamine esters can be converted to aryloxy propanolamine amides, which are useful as drugs for the treatment of obesity and Type II diabetes, and as feed additives for livestock to produce leaner meat.
[EN] ARYLOXY PROPANOLAMINES FOR IMPROVING LIVESTOCK PRODUCTION<br/>[FR] ARYLOXY-PROPANOLAMINES DESTINEES A AMELIORER LA PRODUCTION DE BETAIL
申请人:LILLY CO ELI
公开号:WO2001036413A1
公开(公告)日:2001-05-25
Disclosed is a compound represented by structural formula (I); R1 is a substituted or unsubstituted aryl group. R2 and R3 are independently -H, a C1-C4 straight chained or branched alkyl group. R4 and R5 are independently -H, a C1-C4 straight chained or branched alkyl group or, taken together with the nitrogen atom to which each is bonded, a non-aromatic heterocyclic ring. Ring A and Ring B are independently further substituted with zero, one or two substituents. Physiologically acceptable salts of structural formula shown above are also included. Also disclosed is a method promoting growth, efficiency of feed utilization and/or production of lean body mass in a livestock animal. The method comprises administering to the animal an effective amount of one or more compounds represented by the structural formula as shown or a physiologically acceptable salt thereof.
[EN] TREATING WASTING SYNDROMES WITH ARYLOXY PROPANOLAMINES<br/>[FR] TRAITEMENT DES SYNDROMES CACHECTIQUES AU MOYEN DE PROPANOLAMINES ARYLOXY
申请人:LILLY CO ELI
公开号:WO2001035947A2
公开(公告)日:2001-05-25
Disclosed is a method of treating a subject with a Wasting Syndrome. The method comprising the step of administering to the subject an effective amount of a compound represented by Structural Formula (I), Ar is a substituted or unsubstituted aryl group. Ar is preferably a monocyclic heteroaryl group or a fused polycyclic heteroaryl group. Ring A has zero, one or more additional substituents. R1 and R2 are independently -H or a C1-C4 alkyl group. W is -CH2-, -CH2CH2- or -CH2CH2CH2-. R3 is a substituted or unsubstituted phenyl or pyridyl group.
Aryloxy propanolamines for improving livestock production
申请人:Hopkins Randall Bruce
公开号:US06841563B1
公开(公告)日:2005-01-11
Disclosed is a compound represented by structural formula (I): R1 is a substituted or unsubstituted aryl group. R2 and R3 are independently —H, a C1-C4 straight chained or branched alkyl group. R4 and R5 are independently —H, a C1-C4 straight chained or branched alkyl group or, taken together with the nitrogen atom to which each is bonded, a non-aromatic heterocyclic ring. Ring A and Ring B are independently further substituted with zero, one or two substituents. Physiologically acceptable salts of structural formula shown above are also included. Also disclosed is a method promoting growth, efficiency of feed utilization and/or production of lean body mass in a livestock animal. The method comprises administering to the animal an effective amount of one or more compounds represented by the structural formula as shown or a physiologically acceptable salt thereof.